Compare GGG & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GGG | COO |
|---|---|---|
| Founded | 1926 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 15.5B |
| IPO Year | N/A | N/A |
| Metric | GGG | COO |
|---|---|---|
| Price | $83.61 | $81.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $94.00 | $85.82 |
| AVG Volume (30 Days) | 883.0K | ★ 3.3M |
| Earning Date | 01-26-2026 | 12-04-2025 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | ★ 3.48 | N/A |
| EPS | ★ 2.93 | 1.87 |
| Revenue | $2,192,120,000.00 | ★ $4,092,400,000.00 |
| Revenue This Year | $6.75 | $6.66 |
| Revenue Next Year | $4.83 | $5.54 |
| P/E Ratio | ★ $28.50 | $43.53 |
| Revenue Growth | 2.85 | ★ 5.06 |
| 52 Week Low | $72.06 | $61.78 |
| 52 Week High | $91.00 | $104.47 |
| Indicator | GGG | COO |
|---|---|---|
| Relative Strength Index (RSI) | 57.98 | 72.89 |
| Support Level | $81.32 | $75.25 |
| Resistance Level | $83.16 | $78.69 |
| Average True Range (ATR) | 1.46 | 2.48 |
| MACD | 0.34 | 0.47 |
| Stochastic Oscillator | 84.01 | 55.39 |
Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.1 billion in sales in 2024.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.